2 Growth Stocks I’d Buy Before September

I’m still bullish on the red-hot healthcare sector and growth stocks like Andlauer Healthcare Group Inc. (TSX:AND) in 2022.

| More on:
Upwards momentum

Image source: Getty Images

Canadian markets have been hit hard by volatility in the final days of August. The S&P/TSX Composite Index was down 81 points in early afternoon trading on August 31. However, the S&P/TSX Capped Health Care Index was up 3.3% at the time of this writing. Indeed, the healthcare space has rivalled the technology sector in its explosiveness in North America in recent years. Today, I want to focus on two growth stocks that have thrived in the healthcare sector. Let’s dive in.

This exciting growth stock is undervalued in the healthcare space

Andlauer Healthcare (TSX:AND) is the first growth stock in the healthcare sector I’d suggest investors pick up before September. This Toronto-based supply chain management company provides a platform of third-party custom logistics (3PL) and specialized transportation solutions for the healthcare sector in North America. That means investors will get exposure to two promising industries. Shares of this growth stock have dropped 2.5% so far in 2022. Andlauer is still up 12% over the prior year.

Market researcher MarketsAndMarkets released a report on the supply chain management space earlier this year. It projected that the global supply chain management market would grow from US$28.9 billion in 2022 to US$45.2 billion by 2027. That would represent a compound annual growth rate (CAGR) of 9.4% over the forecast period.

This company unveiled its second-quarter fiscal 2022 earnings on August 9. It delivered revenue growth of 58% to $169 million and operating income growth of 60% to $30.2 million. Moreover, total comprehensive income was reported at $27.6 million, or $0.49 per diluted share — up from $13.1 million, or $0.33 per diluted share, in the previous year.

Shares of this growth stock currently possess a favourable price-to-earnings ratio of 22. That puts this stock in favourable value territory compared to its industry peers. It is geared up for big earnings growth in the years ahead.

Don’t sleep on this growth stock that also offers monthly income

Savaria (TSX:SIS) is the second growth stock in the healthcare sector that I’d look to snatch up on the last day of August. The Laval-based company provides accessibility solutions for the elderly and physically challenged people in North America and around the world. This growth stock has plunged 25% so far in 2022.

Grand View Research estimated that the global personal mobility devices market was valued at US$14.9 billion in 2021. The report projects that this market will achieve a CAGR of 6.3% from 2022 through to 2030. The market can achieve this on the back of an aging population and advances in the personal mobility device industry.

The company released its second-quarter fiscal 2022 results on August 10. It delivered revenue growth of 7.5% to $192 million and gross profit jumped 9.5% to $65.6 million. EBITDA (earnings before interest, taxes, depreciation, and amortization) is a measurement that aims to give a more accurate picture of a company’s profitability. Savaria achieved adjusted EBITDA growth of 14% to $31.5 million in the second quarter of fiscal 2022.

This growth stock is trading in attractive value territory compared to its industry competitors. Better yet, it last paid out a monthly dividend of $0.042 per share. That represents a 3.6% yield.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Andlauer Healthcare Group Inc. The Motley Fool recommends Savaria Corp.

More on Investing

analyze data
Dividend Stocks

The Best Dividend Stocks in Canada Right Now

Earn worry-free income from these best Canadian dividend stocks.

Read more »

Value for money
Dividend Stocks

3 Top Canadian Value Stocks in December 2023

Not all undervalued stocks are worth buying. You should look into the fundamental strengths of the stocks and reconcile value…

Read more »

calculate and analyze stock

2 TSX Stocks to Dominate the Market in 2024

Two stocks with market-beating returns with one month to go this year are the frontrunners to dominate the market in…

Read more »

Young woman sat at laptop by a window

SPY Stock Is Just the Tip of the Iceberg for Canadians Investing in the U.S.

These two BMO ETFs are great alternatives to just buying SPY.

Read more »

TFSA and coins
Stocks for Beginners

How a BIG New TFSA Change Could Affect You in 2024

Canadians are in for a BIG surprise for the TFSA in 2024. Here's how TFSA changes could help you keep…

Read more »

Growing plant shoots on coins
Dividend Stocks

2 Under-the-Radar Dividend Payers With Solid Growth Prospects in 2024

These under the radar monthly dividend payers could provide good growth prospects in 2024 and beyond.

Read more »

Bank Stocks

3 Reasons I’m Buying Royal Bank Stock Today

Royal Bank (TSX:RY) stock has shown signs of strength and yet still put aside $720 million in provisions for loan…

Read more »

Business success with growing, rising charts and businessman in background
Tech Stocks

Growth Stocks: A Once-in-a-Lifetime Opportunity to Get Rich

Here's why investing in quality growth stocks such as Docebo and Datadog may allow you to generate sizeable returns.

Read more »